Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
QuintilesIMS
Accenture
Merck
Dow
Moodys
McKinsey
Harvard Business School

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PREGABALIN

« Back to Dashboard

Clinical Trials for Pregabalin

Trial ID Title Status Sponsor Phase Summary
NCT00035412 St. John's Wort Versus Placebo in Social Phobia Completed National Center for Complementary and Integrative Health (NCCIH) Phase 2 The purpose of this study is to determine the effectiveness of St. John’s Wort as compared to placebo (an inactive substance) in the treatment of outpatients with social phobia.
NCT00141219 Pregabalin Peripheral Neuropathic Pain Study Completed Pfizer Phase 3 To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with peripheral neuropathic pain.
NCT00141245 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. Completed Pfizer Phase 3 To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.
NCT00141258 Pregabalin Epilepsy Add-On Trial Completed Pfizer Phase 3 To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures
NCT00141336 To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. Completed Pfizer Phase 3 To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.
NCT00141362 Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain. Completed Pfizer Phase 3 Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.
NCT00141375 To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. Completed Pfizer Phase 3 To evaluate long-term safety and efficacy of pregabalin in the treatment of neuropathic pain after spinal cord injury.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pregabalin

Condition Name

Condition Name for Pregabalin
Intervention Trials
Healthy 31
Fibromyalgia 31
Pain 29
Neuropathic Pain 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pregabalin
Intervention Trials
Neuralgia 73
Pain, Postoperative 43
Diabetic Neuropathies 35
Fibromyalgia 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pregabalin

Trials by Country

Trials by Country for Pregabalin
Location Trials
Japan 129
Canada 111
India 84
United Kingdom 77
China 72
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pregabalin
Location Trials
Florida 64
California 63
Texas 58
New York 54
Ohio 51
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pregabalin

Clinical Trial Phase

Clinical Trial Phase for Pregabalin
Clinical Trial Phase Trials
Phase 4 117
Phase 3 115
Phase 2/Phase 3 9
[disabled in preview] 93
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pregabalin
Clinical Trial Phase Trials
Completed 226
Recruiting 51
Terminated 27
[disabled in preview] 77
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pregabalin

Sponsor Name

Sponsor Name for Pregabalin
Sponsor Trials
Pfizer 158
Tel-Aviv Sourasky Medical Center 5
GL Pharm Tech Corporation 5
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pregabalin
Sponsor Trials
Other 248
Industry 222
NIH 13
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Merck
Daiichi Sankyo
Moodys
Healthtrust
Johnson and Johnson
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.